Skip to content

A randomized pilot study on probiotics and their effect on vitamin K2 status

A randomized pilot study on probiotics and their effect on vitamin K2 status - ProVitaK

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46101
Enrollment
20
Registered
2019-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitamine status nutritional status vitamin K status

Interventions

A daily sachet of 4 gram freeze-dried probiotics producing 180 µg vitamin K2 to be dissolved in lukewarm water with a slight vanilla taste.

Sponsors

Winclove B.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * High cardiovascular risk without type 2 diabetes * at least 1 of the following risk factors: o systolic blood pressure > 140mm Hg, diastolic blood pressure > 90 mmHg or use of blood pressure lowering medication and/or o impaired glucose tolerance * 2 hour glucose levels of 7.8 to 11.0 mmol/L after 75 gram oral glucose tolerance test o Family history of cardiovascular disease 6.5 mmol/l or use of statins o Smokers * 50 years o Estimated glomerular filtration rate

Exclusion criteria

Exclusion criteria: * Pregnancy, lactation or a female planning to conceive within the study period * Diabetes of any type. * Age 39 kg/m2 * Using vitamin supplements that contain vitamin K, or unwilling to stop two weeks before randomization.

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: The main study parameter is the difference in vitamin K status as assessed by plasma dp-ucMGP between the 2 groups after 12 weeks.

Secondary

MeasureTime frame
Secondary study parameters/endpoints after 12 weeks Vitamin K metabolites in 24-urine collection: metabolites 5C en 7C-aglycone. Vitamin K metabolites in stool: vitamin K1 and MK4 and MK-7 after 12 weeks in participants.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)